Jejunal feeding is followed by a greater rise in plasma cholecystokinin, peptide YY, glucagon-like peptide 1, and glucagon-like peptide 2 concentrations compared with gastric feeding in vivo in humans: a randomized trial.

MLA

Luttikhold, Joanna, et al. “Jejunal Feeding Is Followed by a Greater Rise in Plasma Cholecystokinin, Peptide YY, Glucagon-like Peptide 1, and Glucagon-like Peptide 2 Concentrations Compared with Gastric Feeding in Vivo in Humans: A Randomized Trial.” The American Journal of Clinical Nutrition, vol. 103, no. 2, Feb. 2016, pp. 435–43. EBSCOhost, https://doi.org/10.3945/ajcn.115.116251.

APA

Luttikhold, J., van Norren, K., Rijna, H., Buijs, N., Ankersmit, M., Heijboer, A. C., Gootjes, J., Hartmann, B., Holst, J. J., van Loon, L. J., & van Leeuwen, P. A. (2016). Jejunal feeding is followed by a greater rise in plasma cholecystokinin, peptide YY, glucagon-like peptide 1, and glucagon-like peptide 2 concentrations compared with gastric feeding in vivo in humans: a randomized trial. The American Journal of Clinical Nutrition, 103(2), 435–443. https://doi.org/10.3945/ajcn.115.116251

Chicago

Luttikhold, Joanna, Klaske van Norren, Herman Rijna, Nikki Buijs, Marjolein Ankersmit, Annemieke C Heijboer, Jeannette Gootjes, et al. 2016. “Jejunal Feeding Is Followed by a Greater Rise in Plasma Cholecystokinin, Peptide YY, Glucagon-like Peptide 1, and Glucagon-like Peptide 2 Concentrations Compared with Gastric Feeding in Vivo in Humans: A Randomized Trial.” The American Journal of Clinical Nutrition 103 (2): 435–43. doi:10.3945/ajcn.115.116251.